BridgeBio Oncology Therapeutics, Inc. — SEC Filings
Company ProfileShowing 101–150 of 185 filings
| Date | Form | Description | Size | Accession # |
|---|---|---|---|---|
| Aug 13, 2025 12:29 | SCHEDULE 13D/A | 35.7 KB | 0001213900-25-075307 | |
| Aug 13, 2025 12:28 | 4 | 26.5 KB | 0001213900-25-075305 | |
| Aug 13, 2025 00:54 | 8-K | CURRENT REPORT (1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01) | 3.28 MB | 0001213900-25-075190 |
| Aug 11, 2025 21:08 | 3 | 3.12 KB | 0001213900-25-074387 | |
| Aug 11, 2025 21:07 | 4 | 3.6 KB | 0001213900-25-074383 | |
| Aug 11, 2025 21:05 | 4 | 3.53 KB | 0001213900-25-074379 | |
| Aug 11, 2025 21:04 | 4 | 7.99 KB | 0001213900-25-074375 | |
| Aug 11, 2025 21:01 | 4 | 7.99 KB | 0001213900-25-074368 | |
| Aug 11, 2025 21:00 | 4 | 8 KB | 0001213900-25-074364 | |
| Aug 06, 2025 11:34 | 8-K | CURRENT REPORT (7.01,9.01) | 209 KB | 0001213900-25-072312 |
| Aug 04, 2025 20:46 | 425 | CURRENT REPORT | 60.8 KB | 0001213900-25-071396 |
| Aug 04, 2025 20:45 | 8-K | CURRENT REPORT (5.07) | 236 KB | 0001213900-25-071392 |
| Aug 01, 2025 20:47 | 10-Q | QUARTERLY REPORT | 3.53 MB | 0001213900-25-070659 |
| Jul 30, 2025 20:15 | SCHEDULE 13G/A | 19.1 KB | 0001104659-25-072172 | |
| Jul 25, 2025 01:05 | SCHEDULE 13G | 17.1 KB | 0000950170-25-098552 | |
| Jul 22, 2025 01:05 | 424B3 | PROSPECTUS SUPPLEMENT | 136 KB | 0001213900-25-066296 |
| Jul 21, 2025 12:10 | 425 | FORM 425 | 20.7 KB | 0001213900-25-065883 |
| Jul 11, 2025 11:46 | 425 | CURRENT REPORT | 55.7 KB | 0001213900-25-062956 |
| Jul 11, 2025 11:44 | 8-K | CURRENT REPORT (7.01,9.01) | 235 KB | 0001213900-25-062955 |
| Jul 11, 2025 04:15 | EFFECT | (,,) | 2.6 KB | 9999999995-25-002217 |
| Jul 10, 2025 21:25 | 424B4 | PROSPECTUS | 46.7 MB | 0001213900-25-062864 |
| Jul 09, 2025 14:30 | CORRESP | 9.95 KB | 0001213900-25-062226 | |
| Jul 09, 2025 14:26 | S-4/A | REGISTRATION STATEMENT | 75 MB | 0001213900-25-062224 |
| Jul 01, 2025 21:08 | CORRESP | 33.7 KB | 0001213900-25-060460 | |
| Jul 01, 2025 21:08 | S-4/A | REGISTRATION STATEMENT | 75 MB | 0001213900-25-060456 |
| Jun 27, 2025 16:36 | UPLOAD | 45.6 KB | 0000000000-25-006779 | |
| Jun 20, 2025 21:39 | CORRESP | 21.4 KB | 0001213900-25-056324 | |
| Jun 20, 2025 21:34 | S-4 | REGISTRATION STATEMENT | 77.1 MB | 0001213900-25-056321 |
| Jun 11, 2025 16:36 | UPLOAD | 43.7 KB | 0000000000-25-006146 | |
| May 30, 2025 21:24 | DRSLTR | 61.9 KB | 0001213900-25-049565 | |
| May 30, 2025 21:18 | DRS/A | 43.3 MB | 0001213900-25-049554 | |
| May 15, 2025 21:26 | 10-Q | QUARTERLY REPORT | 3.42 MB | 0001213900-25-044424 |
| May 13, 2025 11:36 | UPLOAD | 77.9 KB | 0000000000-25-005054 | |
| Apr 22, 2025 15:06 | SCHEDULE 13G/A | 10.4 KB | 0002052113-25-000396 | |
| Apr 15, 2025 21:04 | SCHEDULE 13G | 10.4 KB | 0002052113-25-000302 | |
| Apr 15, 2025 01:52 | DRS | 37.6 MB | 0001213900-25-031720 | |
| Apr 15, 2025 01:54 | DRSLTR | 24.1 KB | 0001213900-25-031721 | |
| Mar 11, 2025 00:31 | 10-K | ANNUAL REPORT | 4.39 MB | 0001213900-25-022387 |
| Mar 06, 2025 21:31 | 425 | FORM 425 | 256 KB | 0001213900-25-021210 |
| Mar 04, 2025 23:43 | SCHEDULE 13D/A | 32.3 KB | 0001213900-25-020316 | |
| Mar 01, 2025 02:58 | 425 | CURRENT REPORT | 2.48 MB | 0001213900-25-018999 |
| Mar 01, 2025 02:56 | 8-K | CURRENT REPORT (1.01,3.02,9.01) | 3.18 MB | 0001213900-25-018997 |
| Feb 28, 2025 13:05 | 425 | CURRENT REPORT | 20 MB | 0001213900-25-018335 |
| Feb 28, 2025 13:03 | 8-K | CURRENT REPORT (7.01,9.01) | 20.2 MB | 0001213900-25-018334 |
| Feb 11, 2025 22:16 | 3 | 4.7 KB | 0001213900-25-012280 | |
| Feb 10, 2025 22:07 | 4 | 7.38 KB | 0001213900-25-011813 | |
| Feb 10, 2025 22:06 | 4 | 7.03 KB | 0001213900-25-011810 | |
| Feb 10, 2025 11:05 | 8-K | CURRENT REPORT (5.02,9.01) | 262 KB | 0001213900-25-011454 |
| Nov 14, 2024 21:30 | 10-Q | QUARTERLY REPORT | 3.25 MB | 0001213900-24-098483 |
| Nov 14, 2024 18:22 | SC 13G | 6.44 KB | 0000080255-24-001487 |